Page last updated: 2024-11-08

triiodothyronine and Hutchinson Gilford Progeria Syndrome

triiodothyronine has been researched along with Hutchinson Gilford Progeria Syndrome in 1 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guernsey, DL1
Koebbe, M1
Thomas, JE1
Myerly, TK1
Zmolek, D1

Other Studies

1 other study available for triiodothyronine and Hutchinson Gilford Progeria Syndrome

ArticleYear
An altered response in the induction of cell membrane (Na + K)ATPase by thyroid hormone is characteristic of senescence in cultured human fibroblasts.
    Mechanisms of ageing and development, 1986, Volume: 33, Issue:3

    Topics: Adolescent; Aged; Aging; Cell Line; Cell Membrane; Enzyme Induction; Female; Fibroblasts; Humans; In

1986